Marilyn Lennon

Professor Marilyn Lennon is a leading academic in the Department of Computer and Information Sciences at the University of Strathclyde, holding the title of Professor in Digital Health and Care. She founded and directs the Digital Health and Wellness Group (DHaWG), focusing on multidisciplinary research for designing, evaluating, and implementing digital technologies that enhance individual and population health and wellbeing.

• First class BSc in Psychology (University of Glasgow, 1998)
• PhD in Computing Science (University of Glasgow, 2002)
• Postgraduate diploma in academic practice (Fellow of Higher Education Academy)

With over two decades of experience in Human-Computer Interaction (HCI), usability, and user-centered design, her research spans wearable and mobile technologies for home healthcare, including remote monitoring (predictive falls monitoring), remote diagnosis (colon capsule technology evaluations), and smart home solutions for social care. She specializes in addressing technical and social barriers to real-world health technology implementation, emphasizing robust yet rapid evaluation methods.

Recent publications highlight her work in 3D healthcare visualization, telehealth implementation, and medication management systems. Her research combines lab-based usability testing with real-world ('in the wild') evaluations of technologies like smart home systems and telehealth solutions. Key trends include cross-disciplinary collaboration, accessibility for sensory-impaired individuals, and AI-driven healthcare innovations.

Scientific Awards

• MyCity: Glasgow - Gamechanger Award (Gold Medal) 2025
• Images of Research 2025 Shortlist
• Emerald Outstanding Paper Award 2013
• Best Paper Award (most replicable scientific paper) 2013

As course director for the Masters in Digital Health Systems, she has supervised 5 PhD students (2 completed) and over 100 honors projects. Current projects include the No Need to Fall initiative funded by the Health Foundation (£400k) and the PREMIO project co-creating clinical trials in advanced breast cancer. She maintains active collaborations with NHS, charities, and international institutions like the University of Waterloo.